BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 156581)

  • 21. Non T lymphoid cells can express T cell surface characteristics: normal, HCL, and a range of leukemic B cells express T cell antigens after appropriate in vitro stimulation.
    Worman CP; Mills KH; Cawley JC
    Semin Oncol; 1984 Dec; 11(4):401-4. PubMed ID: 6334367
    [No Abstract]   [Full Text] [Related]  

  • 22. T and B lymphocyte antigen-positive null cell leukemias.
    Kaplan J; Ravindranath Y; Peterson WD
    Blood; 1977 Mar; 49(3):371-8. PubMed ID: 65190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N; Derre M; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appearance of B- or T-lymphocyte markers after diffusion chamber culture of acute lymphoblastic leukemia cells.
    Thiel E; Lau B; Rodt H; Jäger G; Pachmann K
    Blut; 1981 May; 42(5):315-22. PubMed ID: 6972241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 26. T-cell qualities of lymphocytes and/or leukemic cells from peripheral blood in acute myeloid and lymphatic leukemia before treatment and at relapse.
    de Vaan GA; Bakkeren JA; Schretlen ED
    Biomedicine; 1975 Nov; 22(6):524-31. PubMed ID: 1083749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purine nucleoside phosphorylase activity in acute lymphoblastic leukemia.
    Blatt J; Reaman GH; Levin N; Poplack DG
    Blood; 1980 Sep; 56(3):380-2. PubMed ID: 6773605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia.
    Fu SM; Chiorazzi N; Kunkel HG
    Immunol Rev; 1979; 48():23-44. PubMed ID: 232686
    [No Abstract]   [Full Text] [Related]  

  • 29. Human thymus/leukemia-associated antigen in normal and leukemic cells.
    Chechik BE; Pyke KW; Gelfand EW
    Int J Cancer; 1976 Nov; 18(5):551-6. PubMed ID: 825476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface markers and other characteristics of the lymphocyte in chronic lymphocytic leukemia.
    Bentwich Z; Polliack A; Douglas SD
    Isr J Med Sci; 1976; 12(4-5):304-22. PubMed ID: 1084879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased T-cell reactivity to leukemic B cells in chronic lymphocytic leukemia with change of stable disease to its progressive form.
    Fernandez LA; MacSween JM; Langley GR
    Am J Hematol; 1981; 10(2):137-43. PubMed ID: 6453527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of leukemic T-cell lines, B-cell lines, and null-cell line: a progress report on surface antigen study of fresh lymphatic leukemias in man.
    Minowada J; Tsubota T; Nakazawa S; Srivastava BI; Huang CC; Oshimura M; Sonta S; Han T; Sinks LF; Sandberg AA
    Haematol Blood Transfus; 1977; 20():241-51. PubMed ID: 305398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
    Negoro S; Seon BK
    Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunity.
    Weksler ME
    J Immunol; 1976 Feb; 116(2):310-4. PubMed ID: 55437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts.
    Orgad S; Yunis EJ; Zaizov R; Ramot B; Altshuler R; Gazit E
    Hum Immunol; 1984 Feb; 9(2):67-74. PubMed ID: 6421779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human B-cell antigens in acute lymphocytic leukemia. Lack of correlation with other lymphocyte surface markers.
    Mann DL; Kundsen BB; Yarbro GC; Leventhal BG
    J Natl Cancer Inst; 1979 Jul; 63(1):49-53. PubMed ID: 156279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptors for sheep erythrocytes (E) and erythrocyte-antibody-complement complexes (EAC) on the lymphoblasts of childhood acute lymphocyblastic leukemia.
    Nakazawa S; Minowada J; Sinks LF
    Med Pediatr Oncol; 1976; 2(2):147-55. PubMed ID: 1085410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth of the Reh cell line in diffusion chambers. Evidence for differentiation along the T- and B-cell pathway.
    Lau B; Jäger G; Thiel E; Rodt H; Huhn D; Pachmann K; Netzel B; Böning L; Thierfelder S; Dörmer P
    Scand J Haematol; 1979 Oct; 23(4):385-92. PubMed ID: 395638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable MLC stimulatory capacity of neoplastic B and non-B/non-T lymphocytes expressing HLA-DR antigens.
    Bom-van Noorloos AA; Schreuder I; de Groot-Swings G; Ubels-Postma J; von dem Borne AE; Melief CJ
    Tissue Antigens; 1982 Nov; 20(5):352-63. PubMed ID: 6218653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.